重组 RSVB Post-fusion glyco蛋白 F/

重组 RSVB Post-fusion glyco蛋白 F/ RSV post-F 蛋白 (His Tag)（产品说明）
蛋白名称：Human RSVB Post-fusion glycoprotein F/ RSV post-F Protein (His Tag)(MALS-verified)
表达宿主：HEK293 Cells
蛋白纯度：≥ 90 % as determined by SDS-PAGE. ≥ 90 % as determined by SEC-MALS.
蛋白活性：1.Immobilized Recombinant RSVB Post-fusion glycoprotein F/ RSV post-F Protein (His Tag) (Cat: 40999-V08H) at 1 μg/mL (100μL/well) can bind Anti-Fusion glycoprotein F0 Antibody, Human IgG1 (site II) (Palivizumab), the EC50 is 10-30 ng/mL and not bind Anti-Fusion glycoprotein F0 Antibody, Human IgG1 (Site Ø) (Nirsevimab). 2.Immobilized Human respiratory syncytial virus(RSV)(A2)Prefusion glycoprotein F/RSV-preF Protein (Cat: 11049-VNAS) at 1 μg/mL (100μL/well) can bind Anti-Fusion glycoprotein F0 Antibody, Human IgG1 (Site Ø)(Nirsevimab), the EC50 is 6-18 ng/mL. Recombinant RSVB Post-fusion glycoprotein F/ RSV post-F Protein (His Tag) (Cat: 40999-V08H) is verified not recoginized by Anti-Fusion glycoprotein F0 Antibody, Human IgG1 (Site Ø) (Nirsevimab).
蛋白内毒素：< 1.0 EU per μg of the protein as determined by the LAL method
蛋白分子量：The recombinant RSVB (BA9）Post-fusion glycoprotein F/ RSV post-F has a predicted molecular mass of 56.13 kDa.It migrates as an approximately 42.3 kDa and 21.1 kDa band in SDS-PAGE under reducing conditions. The molecular weight of this protein is around 170.8 kDa verified by SEC-MALS.